Enhanced susceptibility of Staphylococcus aureus pretreated with cefepime and cefpodoxime to leukocyte activity.
Herrera
I
I
Department of Microbiology, Faculty of Medicine, Complutense University of Madrid, Spain.
Martinez
P
P
Perez
P
P
Garcia
Y
Y
Gomez-Lus
M L
ML
Prieto
J
J
D001770:Blood Bactericidal Activity; D000077723:Cefepime; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D006801:Humans; D009504:Neutrophils / Q000276:immunology*; D010587:Phagocytosis; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000276:immunology; D000097623:Cefpodoxime
D000077723:Cefepime; D015296:Ceftizoxime; D002511:Cephalosporins; D000097623:Cefpodoxime